Acute Promyelocytic Leukemia Following Etoposide-Based Combination Chemotherapy for Letterer-Siwe Disease.
スポンサーリンク
概要
- 論文の詳細を見る
A case of acute promyelocytic leukemia following etoposide-based combination chemotherapy for Letterer-Siwe disease is reported. The patient was a 3-year-4-month-old girl who had been treated with vincristine, cyclophosphamide, methotrexate, prednisolone and etoposide because of Letterer-Siwe disease diagnosed by bone marrow examination and lymph node biopsy at the age of 5 moths. The total cumulative dose of etoposide was 4, 800 mg/m<SUP>2</SUP>. She had remained well for 9 months after completion of chemotherapy. Then she came to our hospital with fever and purpura. Bone marrow examination confirmed a diagnosis of acute promyelocytic leukemia. The bone marrow karyotype was 46, XX, t (15; 17) (q22, q12). She was treated with BFM-83 protocol and attained remission after induction chemotherapy. But she died of heart failure after one year of consolidation chemotherapy. The risk of developing secondary leukemia in high-dose etoposide therapy is discussed.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma